Nusirt Sciences Financing
Nusirt Sciences Inc., Corporation just released form D for $2.00 million equity financing. This is a new filing. Nusirt Sciences was able to sell $2.00 million. That is 100.00% of the offering. The total private financing amount was $2.00 million. The fundraising form was filed on 2016-12-01. The reason for the financing was: unspecified.
Nusirt Sciences is based in Tennessee. The filler’s business is Pharmaceuticals. The form D was signed by Barbara Cannon Chief Operating Office. The company was incorporated in 2012. The filler’s address is: 3835 Cleghorn Avenue Suite 200, Nashville, Tn, Tennessee, 37215. Barbara Cannon is the related person in the form and it has address: 3835 Cleghorn Avenue, Suite 200, Nashville, Tn, Tennessee, 37215. Link to Nusirt Sciences Filing: 000164223916000003.
Analysis of Nusirt Sciences Offering
On average, companies in the Pharmaceuticals sector, sell 60.90% of the total offering amount. Nusirt Sciences sold 100.00% of the offering. Could this mean that the trust in Nusirt Sciences is high? The average fundraising size for companies in the Pharmaceuticals industry is $556,000. The total amount raised is 259.71% bigger than the average for companies in the Pharmaceuticals sector. The minimum investment for this fundraising is set at $4989. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Nusirt Sciences Also
The Form D signed by Barbara Cannon might help Nusirt Sciences Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.